ROCHE PRODUCTS INC. – Trademark Portfolio

Entity Type: 03

ROCHE PRODUCTS INC. holds 14 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 14 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include LIBRAX and VALIUM. The owner is based in KM 2.7. MANATI, PR.

STATE ROAD NO. 670

KM 2.7. MANATI, PR

14 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

V
V
Cancelled 1984
FLEXTAB
FLEXTAB
Cancelled 1980
QUARZAN
QUARZAN
Cancelled 1976
ENDEP
ENDEP
Cancelled 1975
DALMANE
DALMANE
Cancelled 1966
MENRIUM
MENRIUM
Cancelled 1963
RELEASE
RELEASE
Cancelled 1962
VALIUM
VALIUM
Registered 1961
LIBRAX
LIBRAX
Registered 1961
LIBRIUM
LIBRIUM
Cancelled 1959

Trademark Classifications

ROCHE PRODUCTS INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (14 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does ROCHE PRODUCTS INC. have?

ROCHE PRODUCTS INC. has 14 U.S. trademarks filed with the USPTO. Of these, 2 registered, 12 cancelled.

What trademark classes does ROCHE PRODUCTS INC. file in?

ROCHE PRODUCTS INC. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are ROCHE PRODUCTS INC.'s most well-known trademarks?

ROCHE PRODUCTS INC.'s registered trademark portfolio includes well-known marks such as LIBRAX and VALIUM. These are among 2 currently registered trademarks in the portfolio.

What is ROCHE PRODUCTS INC.'s trademark registration success rate?

ROCHE PRODUCTS INC. has a 14% trademark registration rate, with 2 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.